The store will not work correctly when cookies are disabled.
2-(furan-2-yl)-3-((4-methoxyphenyl)amino)-4H-chromen-4-one
ID: ALA4279484
PubChem CID: 145979629
Max Phase: Preclinical
Molecular Formula: C20H15NO4
Molecular Weight: 333.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(Nc2c(-c3ccco3)oc3ccccc3c2=O)cc1
Standard InChI: InChI=1S/C20H15NO4/c1-23-14-10-8-13(9-11-14)21-18-19(22)15-5-2-3-6-16(15)25-20(18)17-7-4-12-24-17/h2-12,21H,1H3
Standard InChI Key: LNEPHSDSMCDPMW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
4.8985 -20.0790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8974 -20.9063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6122 -21.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6104 -19.6662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3257 -20.0754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3246 -20.9038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0376 -21.3168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7563 -20.9058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7574 -20.0774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0399 -19.6598 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4707 -19.6656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2236 -20.0030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7772 -19.3912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3663 -18.6757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5590 -18.8453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0352 -22.1418 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4695 -21.3203 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4672 -22.1453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7523 -22.5515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7496 -23.3758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4634 -23.7911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1814 -23.3762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1806 -22.5533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4622 -24.6160 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7472 -25.0275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 2 0
9 11 1 0
7 16 2 0
8 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.34 | Molecular Weight (Monoisotopic): 333.1001 | AlogP: 4.81 | #Rotatable Bonds: 4 |
Polar Surface Area: 64.61 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.38 | CX Basic pKa: ┄ | CX LogP: 3.06 | CX LogD: 3.06 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.58 | Np Likeness Score: -0.53 |
References
1. Parveen I, Khan P, Ali S, Hassan MI, Ahmed N.. (2018) Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors., 159 [PMID:30290280] [10.1016/j.ejmech.2018.09.030] |